Khan I, Rehman W, Rasheed L, Rahim F, Hussain R, Khan S
ACS Omega. 2024; 9(28):31148-31158.
PMID: 39035878
PMC: 11256303.
DOI: 10.1021/acsomega.4c04599.
Kechi E, Ubah C, Runde M, Owen A, Godfrey O, Agurokpon D
In Silico Pharmacol. 2024; 12(1):48.
PMID: 38828443
PMC: 11139824.
DOI: 10.1007/s40203-024-00222-3.
Huo L, Liu X, Jaiswal Y, Xu H, Chen R, Lu R
Int J Mol Sci. 2023; 24(1).
PMID: 36613504
PMC: 9820444.
DOI: 10.3390/ijms24010064.
Celik I, Acar Cevik U, Karayel A, Isik A, Kayis U, Gul U
ACS Omega. 2022; 7(50):47015-47030.
PMID: 36570216
PMC: 9773947.
DOI: 10.1021/acsomega.2c06142.
Elganzory H, M Alminderej F, El-Bayaa M, Awad H, Nossier E, El-Sayed W
Molecules. 2022; 27(20).
PMID: 36296551
PMC: 9611297.
DOI: 10.3390/molecules27206960.
Synthesis, Molecular Docking Study, and Cytotoxicity Evaluation of Some Novel 1,3,4-Thiadiazole as Well as 1,3-Thiazole Derivatives Bearing a Pyridine Moiety.
Abouzied A, Al-Humaidi J, Bazaid A, Qanash H, Binsaleh N, Alamri A
Molecules. 2022; 27(19).
PMID: 36234908
PMC: 9572991.
DOI: 10.3390/molecules27196368.
Synthesis, Characterization, and In Vivo Study of Some Novel 3,4,5-Trimethoxybenzylidene-hydrazinecarbothioamides and Thiadiazoles as Anti-Apoptotic Caspase-3 Inhibitors.
Mostafa S, Aly A, Brase S, Nieger M, Abdelhafez S, Abdelzaher W
Molecules. 2022; 27(7).
PMID: 35408692
PMC: 9040718.
DOI: 10.3390/molecules27072266.
Three-Component Synthesis of Some New Coumarin Derivatives as Anticancer Agents.
Alshabanah L, Al-Mutabagani L, Gomha S, Ahmed H
Front Chem. 2022; 9:762248.
PMID: 35145952
PMC: 8822056.
DOI: 10.3389/fchem.2021.762248.
Synthesis, molecular docking, and biological evaluation of Schiff base hybrids of 1,2,4-triazole-pyridine as dihydrofolate reductase inhibitors.
Dewangan D, Vaishnav Y, Mishra A, Jha A, Verma S, Badwaik H
Curr Res Pharmacol Drug Discov. 2021; 2:100024.
PMID: 34909659
PMC: 8663949.
DOI: 10.1016/j.crphar.2021.100024.
Synthesis and Preliminary Anticancer Activity Assessment of N-Glycosides of 2-Amino-1,3,4-thiadiazoles.
Zurawska K, Stokowy M, Kapica P, Olesiejuk M, Kudelko A, Papaj K
Molecules. 2021; 26(23).
PMID: 34885815
PMC: 8659227.
DOI: 10.3390/molecules26237245.
A Focused Review of Synthetic Applications of Lawesson's Reagent in Organic Synthesis.
Khatoon H, Abdulmalek E
Molecules. 2021; 26(22).
PMID: 34834028
PMC: 8618327.
DOI: 10.3390/molecules26226937.
Carbonate-promoted C-H carboxylation of electron-rich heteroarenes.
Porter T, Kanan M
Chem Sci. 2021; 11(43):11936-11944.
PMID: 34123214
PMC: 8162799.
DOI: 10.1039/d0sc04548a.
Design, Synthesis, and Biological Evaluation of 1,2,4-Thiadiazole-1,2,4-Triazole Derivatives Bearing Amide Functionality as Anticancer Agents.
Pragathi Y, Sreenivasulu R, Veronica D, Raju R
Arab J Sci Eng. 2020; 46(1):225-232.
PMID: 32837812
PMC: 7243954.
DOI: 10.1007/s13369-020-04626-z.
Diversity-oriented synthesis and antifungal activities of novel pimprinine derivative bearing a 1,3,4-oxadiazole-5-thioether moiety.
Song Z, Zhu Y, Liu J, Guo S, Gu Y, Han X
Mol Divers. 2020; 25(1):205-221.
PMID: 32056130
DOI: 10.1007/s11030-020-10048-8.
Non-Typical Fluorescence Effects and Biological Activity in Selected 1,3,4-thiadiazole Derivatives: Spectroscopic and Theoretical Studies on Substituent, Molecular Aggregation, and pH Effects.
Budziak I, Karcz D, Makowski M, Rachwal K, Starzak K, Matwijczuk A
Int J Mol Sci. 2019; 20(21).
PMID: 31690061
PMC: 6862516.
DOI: 10.3390/ijms20215494.
Crystal structure of tetra-μ-acetato-bis-[(5-amino-2-methyl-sulfanyl-1,3,4-thia-diazole-κ )copper(II)].
Torambetov B, Kadirova S, Toshmurodov T, Ashurov J, Parpiev N, Ziyaev A
Acta Crystallogr E Crystallogr Commun. 2019; 75(Pt 8):1239-1242.
PMID: 31417799
PMC: 6690473.
DOI: 10.1107/S2056989019010272.
Design, Synthesis, and Molecular Docking Study of Novel Heterocycles Incorporating 1,3,4-Thiadiazole Moiety as Potential Antimicrobial and Anticancer Agents.
El-Naggar M, Sallam H, Shaban S, Abdel-Wahab S, Amr A, Azab M
Molecules. 2019; 24(6).
PMID: 30889918
PMC: 6471095.
DOI: 10.3390/molecules24061066.
Synthesis of new chiral 1,3,4-thiadiazole-based di- and tri-arylsulfonamide residues and evaluation of in vitro anti-HIV activity and cytotoxicity.
Shafique M, Hameed S, Naseer M, Al-Masoudi N
Mol Divers. 2018; 22(4):957-968.
PMID: 29968121
DOI: 10.1007/s11030-018-9851-2.
5-(Thiophen-2-yl)-1,3,4-thiadiazole derivatives: synthesis, molecular docking and in vitro cytotoxicity evaluation as potential anticancer agents.
Gomha S, Edrees M, Muhammad Z, El-Reedy A
Drug Des Devel Ther. 2018; 12:1511-1523.
PMID: 29881258
PMC: 5985782.
DOI: 10.2147/DDDT.S165276.
Spectroscopic and Theoretical Studies of Fluorescence Effects in 2-Methylamino-5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazole Induced by Molecular Aggregation.
Matwijczuk A, Gorecki A, Makowski M, Pustula K, Skrzypek A, Was J
J Fluoresc. 2017; 28(1):65-77.
PMID: 28889356
PMC: 5799588.
DOI: 10.1007/s10895-017-2175-2.